{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T14:16:53Z","timestamp":1769350613136,"version":"3.49.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T00:00:00Z","timestamp":1368748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064118","type":"journal-article","created":{"date-parts":[[2013,5,17]],"date-time":"2013-05-17T21:03:40Z","timestamp":1368824620000},"page":"e64118","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin"],"prefix":"10.1371","volume":"8","author":[{"given":"Bokyung","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahdeo","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek R.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash C.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat B.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"ref1","first-page":"204","article-title":"Osteoclastogenesis\u2013current knowledge and future perspectives","volume":"8","author":"MP Yavropoulou","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"DM Anderson","year":"1997","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI34257","article-title":"Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice","volume":"118","author":"W Jin","year":"2008","journal-title":"J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"DL Lacey","year":"1998","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase","volume":"273","author":"BG Darnay","year":"1998","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"H Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"RE Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"RE Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrclinonc.2010.134","article-title":"Future directions of bone-targeted therapy for metastatic breast cancer","volume":"7","author":"T Onishi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2011.127","article-title":"Bone metastasis in prostate cancer: emerging therapeutic strategies","volume":"8","author":"J Sturge","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.intimp.2012.01.009","article-title":"Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma\/LPS-stimulated BV2 microglia via NF-kappaB signalling pathway","volume":"12","author":"YL Chow","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.bjp.0706856","article-title":"The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes\/macrophages","volume":"149","author":"S Hatziieremia","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"H Hsu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/endo.142.3.8031","article-title":"Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors","volume":"142","author":"S Wei","year":"2001","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1124\/mol.107.034512","article-title":"Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation","volume":"71","author":"B Sung","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1158\/1541-7786.MCR-10-0141","article-title":"Embelin suppresses osteoclastogenesis induced by receptor activator of NF-kappaB ligand and tumor cells in vitro through inhibition of the NF-kappaB cell signaling pathway","volume":"8","author":"S Reuter","year":"2010","journal-title":"Mol Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1074\/jbc.M411189200","article-title":"Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1","volume":"280","author":"Y Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1006\/bbrc.1999.2008","article-title":"Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro","volume":"267","author":"N Chikatsu","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05018.x","article-title":"Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation","volume":"126","author":"FP Lai","year":"2004","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/BF03354642","article-title":"Human endosteal osteoblastic cells: relationship with bone formation","volume":"56","author":"PJ Marie","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.52.1","article-title":"Differentiation and function of osteoclasts","volume":"52","author":"T Miyamoto","year":"2003","journal-title":"Keio J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02555128","article-title":"Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria","volume":"41","author":"S Hanazawa","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption","volume":"145","author":"Y Ishimi","year":"1990","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1359\/jbmr.2002.17.7.1211","article-title":"Dual modulation of osteoclast differentiation by lipopolysaccharide","volume":"17","author":"W Zou","year":"2002","journal-title":"J Bone Miner Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcb.20649","article-title":"Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES","volume":"97","author":"MS Kim","year":"2006","journal-title":"J Cell Biochem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"21132","DOI":"10.1074\/jbc.273.33.21132","article-title":"NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation","volume":"273","author":"M Uhlik","year":"1998","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20030116","article-title":"The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis","volume":"198","author":"DV Novack","year":"2003","journal-title":"J Exp Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","article-title":"The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis","volume":"279","author":"S Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","article-title":"NF-kappaB modulators in osteolytic bone diseases","volume":"20","author":"J Xu","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1359\/jbmr.2002.17.7.1200","article-title":"NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis","volume":"17","author":"L Xing","year":"2002","journal-title":"J Bone Miner Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"YY Kong","year":"1999","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"54841","DOI":"10.1074\/jbc.M406392200","article-title":"Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha","volume":"279","author":"ML Chaisson","year":"2004","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"MG Ruocco","year":"2005","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q","article-title":"The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma","volume":"88","author":"BI Carlin","year":"2000","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"GR Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2141.2007.06629.x","article-title":"Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth","volume":"138","author":"M Jourdan","year":"2007","journal-title":"Br J Haematol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/1078-0432.CCR-06-1559","article-title":"Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells","volume":"13","author":"Y Kishida","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1043-2760(00)00351-9","article-title":"Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone","volume":"12","author":"TJ Martin","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.4049\/jimmunol.172.10.5940","article-title":"Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis","volume":"172","author":"AC Bharti","year":"2004","journal-title":"J Immunol"},{"key":"ref40","volume":"101","unstructured":"Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, <etal>et al<\/etal>.. (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. U S A Proc Natl Acad Sci <volume>101<\/volume>: : 10137\u201310142."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2007.12.1269","article-title":"American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma","volume":"25","author":"RA Kyle","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"AE Kearns","year":"2008","journal-title":"Endocr Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.lfs.2011.06.027","article-title":"Cardamonin suppresses nitric oxide production via blocking the IFN-gamma\/STAT pathway in endotoxin-challenged peritoneal macrophages of ICR mice","volume":"89","author":"A Takahashi","year":"2011","journal-title":"Life Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0028-1097682","article-title":"Cardamonin and alpinetin from the seeds of Amomum subulatum","volume":"29","author":"C Bheemasankara Rao","year":"1976","journal-title":"Planta Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T20:28:28Z","timestamp":1688243308000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064118"}},"subtitle":[],"editor":[{"given":"Anindita","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064118","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}